Suppr超能文献

长期他莫昔芬治疗:子宫癌肉瘤发生的一个可能病因:两例病例报告及文献综述

Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.

作者信息

Fotiou S, Hatjieleftheriou G, Kyrousis G, Kokka F, Apostolikas N

机构信息

Department of Gynecology, Saint Savas Cancer Hospital of Athens, Greece. FosteOTENET.GR

出版信息

Anticancer Res. 2000 May-Jun;20(3B):2015-20.

Abstract

Two cases of uterine carcinosarcoma developing after long-term tamoxifen (TAM) treatment are presented. The patients, 67 and 72 years old, were treated with TAM for 6 and 7 years, continuously. They both developed an heterologous malignant mixed Mullerian tumor (mmMt). At laparotomy, an advanced stage of disease was found with peritoneal spread. In spite of the surgical and the postoperative treatment, they both died of disease, 3 and 10 months later. There are only 10, well documented, similar cases reported. Another 7 were identified in series of uterine malignancies developing after TAM treatment. Considerable evidence suggests that mmMt represents an epithelial cancer with sarcomatous dedifferentiation. Prolonged (> 5 years) TAM treatment may represent a causative factor in the development of this highly lethal disease (80% of the reported patients had a dismal prognosis). Large uterine polyps with special histological features, may represent an intermediate step in the tumor formation. Close follow-up of the patients is warranted.

摘要

本文报告两例长期服用他莫昔芬(TAM)后发生子宫癌肉瘤的病例。两名患者年龄分别为67岁和72岁,持续服用TAM 6年和7年。她们均发生了异源性恶性混合苗勒管肿瘤(mmMt)。剖腹探查时发现疾病已处于晚期并有腹膜播散。尽管进行了手术及术后治疗,但她们分别在3个月和10个月后均死于该疾病。仅有10例记录良好的类似病例报道。在TAM治疗后发生的一系列子宫恶性肿瘤中又发现了另外7例。大量证据表明,mmMt是一种伴有肉瘤样去分化的上皮癌。长期(>5年)TAM治疗可能是这种高致死性疾病发生的一个致病因素(80%的报道患者预后不良)。具有特殊组织学特征的大子宫息肉可能是肿瘤形成的一个中间阶段。对患者进行密切随访是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验